Citations (59)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Quentin Le Bastard, Laureline Berthelot, Jean-Paul Soulillou & Emmanuel Montassier. (2021) Impact of non-antibiotic drugs on the human intestinal microbiome. Expert Review of Molecular Diagnostics 21:9, pages 911-924.
Read now
Read now
Aneseh Adeshirlarijaney & Andrew T. Gewirtz. (2020) Considering gut microbiota in treatment of type 2 diabetes mellitus. Gut Microbes 11:3, pages 253-264.
Read now
Read now
Vemana Gowd, Lianghua Xie, Xiaodong Zheng & Wei Chen. (2019) Dietary fibers as emerging nutritional factors against diabetes: focus on the involvement of gut microbiota. Critical Reviews in Biotechnology 39:4, pages 524-540.
Read now
Read now
Articles from other publishers (56)
Marisel Rosell-Díaz & José Manuel Fernández-Real. (2023) Metformin, Cognitive Function, and Changes in the Gut Microbiome. Endocrine Reviews.
Crossref
Crossref
Zheng Yao, Jia Guo, Bing Du, Li Hong, Ying Zhu, Xiaoyi Feng, Yuanlu Hou & Anhua Shi. (2023) Effects of Shenling Baizhu powder on intestinal microflora metabolites and liver mitochondrial energy metabolism in nonalcoholic fatty liver mice. Frontiers in Microbiology 14.
Crossref
Crossref
Ying Dong, Yingbei Qi, Haowen Jiang, Tian Mi, Yunkai Zhang, Chang Peng, Wanchen Li, Yongmei Zhang, Yubo Zhou, Yi Zang & Jia Li. (2023) The development and benefits of metformin in various diseases. Frontiers of Medicine 17:3, pages 388-431.
Crossref
Crossref
Ye Chen, Xin Shen, Teng Ma, Xia Yu, Lai-Yu Kwok, Yalin Li, Zhihong Sun, Dongmei Li & Heping Zhang. (2023) Adjunctive Probio-X Treatment Enhances the Therapeutic Effect of a Conventional Drug in Managing Type 2 Diabetes Mellitus by Promoting Short-Chain Fatty Acid-Producing Bacteria and Bile Acid Pathways. mSystems 8:1.
Crossref
Crossref
Chris R. Triggle, Ibrahim Mohammed, Khalifa Bshesh, Isra Marei, Kevin Ye, Hong Ding, Ross MacDonald, Morley D. Hollenberg & Michael A. Hill. (2022) Metformin: Is it a drug for all reasons and diseases?. Metabolism 133, pages 155223.
Crossref
Crossref
Laura Di Magno, Fiorella Di Pastena, Rosa Bordone, Sonia Coni & Gianluca Canettieri. (2022) The Mechanism of Action of Biguanides: New Answers to a Complex Question. Cancers 14:13, pages 3220.
Crossref
Crossref
Heather T. Essigmann, Craig L. Hanis, Stacia M. DeSantis, William B. Perkison, David A. Aguilar, Goo Jun, D. Ashley Robinson & Eric L. Brown. (2022) Worsening Glycemia Increases the Odds of Intermittent but Not Persistent Staphylococcus aureus Nasal Carriage in Two Cohorts of Mexican American Adults. Microbiology Spectrum 10:3.
Crossref
Crossref
Wenhui Liu, Zhiying Luo, Jiecan Zhou & Bao Sun. (2022) Gut Microbiota and Antidiabetic Drugs: Perspectives of Personalized Treatment in Type 2 Diabetes Mellitus. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Yating Wan & Tao Zuo. (2022) Interplays between drugs and the gut microbiome. Gastroenterology Report 10.
Crossref
Crossref
U. V. Buyvalenko & E. V. Pokrovskaya. (2022) Interaction between the gut microbiota and oral antihyperglycemic drugs. Problems of Endocrinology 68:2, pages 66-71.
Crossref
Crossref
Jean-Claude Henquin. (2021) Non-glucose modulators of insulin secretion in healthy humans: (dis)similarities between islet and in vivo studies. Metabolism 122, pages 154821.
Crossref
Crossref
Cecilia Marini, Vanessa Cossu, Matteo Bauckneht, Francesco Lanfranchi, Stefano Raffa, Anna Maria Orengo, Silvia Ravera, Silvia Bruno & Gianmario Sambuceti. (2021) Metformin and Cancer Glucose Metabolism: At the Bench or at the Bedside?. Biomolecules 11:8, pages 1231.
Crossref
Crossref
Yujin Lee, Andrew HyoungJin Kim, Eunwoo Kim, SeungHwan Lee, Kyung-Sang Yu, In-Jin Jang, Jae-Yong Chung & Joo-Youn Cho. (2021) Changes in the gut microbiome influence the hypoglycemic effect of metformin through the altered metabolism of branched-chain and nonessential amino acids. Diabetes Research and Clinical Practice 178, pages 108985.
Crossref
Crossref
Noel T. Mueller, Moira K. Differding, Mingyu Zhang, Nisa M. Maruthur, Stephen P. Juraschek, Edgar R. MillerIIIIII, Lawrence J. Appel & Hsin-Chieh Yeh. (2021) Metformin Affects Gut Microbiome Composition and Function and Circulating Short-Chain Fatty Acids: A Randomized Trial. Diabetes Care 44:7, pages 1462-1471.
Crossref
Crossref
Leslie S. Satin, Scott A. Soleimanpour & Emily M. Walker. (2021) New Aspects of Diabetes Research and Therapeutic Development. Pharmacological Reviews 73:3, pages 1001-1015.
Crossref
Crossref
Georgina R. Jones & Mark P. Molloy. (2020) Metformin, Microbiome and Protection Against Colorectal Cancer. Digestive Diseases and Sciences 66:5, pages 1409-1414.
Crossref
Crossref
M. Nazmul Huda, Myungsuk Kim & Brian J. Bennett. (2021) Modulating the Microbiota as a Therapeutic Intervention for Type 2 Diabetes. Frontiers in Endocrinology 12.
Crossref
Crossref
Michelle Jaromy & Joshua D. Miller. (2021) Pharmacologic mechanisms underlying antidiabetic drug metformin’s chemopreventive effect against colorectal cancer. European Journal of Pharmacology 897, pages 173956.
Crossref
Crossref
Chae Bin Lee, Soon Uk Chae, Seong Jun Jo, Ui Min Jerng & Soo Kyung Bae. (2021) The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. International Journal of Molecular Sciences 22:7, pages 3566.
Crossref
Crossref
Daniela Maria Tanase, Evelina Maria Gosav, Ecaterina Neculae, Claudia Florida Costea, Manuela Ciocoiu, Loredana Liliana Hurjui, Claudia Cristina Tarniceriu, Minela Aida Maranduca, Cristina Mihaela Lacatusu, Mariana Floria & Ionela Lacramioara Serban. (2020) Role of Gut Microbiota on Onset and Progression of Microvascular Complications of Type 2 Diabetes (T2DM). Nutrients 12:12, pages 3719.
Crossref
Crossref
Qi-You Ding, Jia-Xing Tian, Min Li, Feng-Mei Lian, Lin-Hua Zhao, Xiu-Xiu Wei, Lin Han, Yu-Jiao Zheng, Ze-Zheng Gao, Hao-Yu Yang, Xin-Yi Fang & Xiao-lin Tong. (2020) Interactions Between Therapeutics for Metabolic Disease, Cardiovascular Risk Factors, and Gut Microbiota. Frontiers in Cellular and Infection Microbiology 10.
Crossref
Crossref
Juan Salazar, Lissé Angarita, Valery Morillo, Carla Navarro, María Sofía Martínez, Maricarmen Chacín, Wheeler Torres, Arush Rajotia, Milagros Rojas, Clímaco Cano, Roberto Añez, Joselyn Rojas & Valmore Bermudez. (2020) Microbiota and Diabetes Mellitus: Role of Lipid Mediators. Nutrients 12:10, pages 3039.
Crossref
Crossref
Chi Zhang, Shuangshuang Ma, Jiahui Wu, Linglong Luo, Sanyang Qiao, Ruxin Li, Wenjuan Xu, Nan Wang, Baosheng Zhao, Xiao Wang, Yuan Zhang & Xueyong Wang. (2020) A specific gut microbiota and metabolomic profiles shifts related to antidiabetic action: The similar and complementary antidiabetic properties of type 3 resistant starch from Canna edulis and metformin. Pharmacological Research 159, pages 104985.
Crossref
Crossref
Priska Stahel, Changting Xiao, Avital Nahmias & Gary F. Lewis. (2020) Role of the Gut in Diabetic Dyslipidemia. Frontiers in Endocrinology 11.
Crossref
Crossref
Tabassum Moonira, Shruti S. Chachra, Brian E. Ford, Silvia Marin, Ahmed Alshawi, Natasha S. Adam-Primus, Catherine Arden, Ziad H. Al-Oanzi, Marc Foretz, Benoit Viollet, Marta Cascante & Loranne Agius. (2020) Metformin lowers glucose 6-phosphate in hepatocytes by activation of glycolysis downstream of glucose phosphorylation. Journal of Biological Chemistry 295:10, pages 3330-3346.
Crossref
Crossref
Rosina Pryor, Daniel Martinez-Martinez, Leonor Quintaneiro & Filipe Cabreiro. (2020) The Role of the Microbiome in Drug Response. Annual Review of Pharmacology and Toxicology 60:1, pages 417-435.
Crossref
Crossref
Andra Iulia-Suceveanu, Sergiu Ioan Micu, Claudia Voinea, Madalina Elena Manea, Doina Catrinoiu, Laura Mazilu, Anca Pantea Stoian, Irinel Parepa, Roxana Adriana Stoica & Adrian-Paul Suceveanu. 2020. Metformin [Working Title]. Metformin [Working Title].
Andreas Brønden & Filip K Knop. (2020) Gluco-Metabolic Effects of Pharmacotherapy-Induced Modulation of Bile Acid Physiology. The Journal of Clinical Endocrinology & Metabolism 105:1, pages 362-373.
Crossref
Crossref
Marc Foretz, Bruno Guigas & Benoit Viollet. (2019) Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus. Nature Reviews Endocrinology 15:10, pages 569-589.
Crossref
Crossref
Natalia G. Vallianou, Theodora Stratigou & Stylianos Tsagarakis. (2019) Metformin and gut microbiota: their interactions and their impact on diabetes. Hormones 18:2, pages 141-144.
Crossref
Crossref
Thomas Bryrup, Cæcilie W. Thomsen, Timo Kern, Kristine H. Allin, Ivan Brandslund, Niklas R. Jørgensen, Henrik Vestergaard, Torben Hansen, Tue H. Hansen, Oluf Pedersen & Trine Nielsen. (2019) Metformin-induced changes of the gut microbiota in healthy young men: results of a non-blinded, one-armed intervention study. Diabetologia 62:6, pages 1024-1035.
Crossref
Crossref
Hartmut H. Glossmann & Oliver M. D. Lutz. (2019) Commentary: Lactate-Induced Glucose Output Is Unchanged by Metformin at a Therapeutic Concentration—A Mass Spectrometry Imaging Study of the Perfused Rat Liver. Frontiers in Pharmacology 10.
Crossref
Crossref
Per G. Farup, Martin Aasbrenn & Jørgen Valeur. (2018) Separating “good” from “bad” faecal dysbiosis – evidence from two cross-sectional studies. BMC Obesity 5:1.
Crossref
Crossref
Ilze Elbere, Ineta Kalnina, Ivars Silamikelis, Ilze Konrade, Linda Zaharenko, Kristine Sekace, Ilze Radovica-Spalvina, Davids Fridmanis, Dita Gudra, Valdis Pirags & Janis Klovins. (2018) Association of metformin administration with gut microbiome dysbiosis in healthy volunteers. PLOS ONE 13:9, pages e0204317.
Crossref
Crossref
Xiaolin Tong, Jia Xu, Fengmei Lian, Xiaotong Yu, Yufeng Zhao, Lipeng Xu, Menghui Zhang, Xiyan Zhao, Jian Shen, Shengping Wu, Xiaoyan Pang, Jiaxing Tian, Chenhong Zhang, Qiang Zhou, Linhua Wang, Bing Pang, Feng Chen, Zhiping Peng, Jing Wang, Zhong Zhen, Chao Fang, Min Li, Limei Chen & Liping Zhao. (2018) Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial. mBio 9:3.
Crossref
Crossref
Wei Ma, Ji Chen, Yuhong Meng, Jichun Yang, Qinghua Cui & Yuan Zhou. (2018) Metformin Alters Gut Microbiota of Healthy Mice: Implication for Its Potential Role in Gut Microbiota Homeostasis. Frontiers in Microbiology 9.
Crossref
Crossref
You Lv, Xue Zhao, Weiying Guo, Ying Gao, Shuo Yang, Zhuo Li & Guixia Wang. (2018) The Relationship between Frequently Used Glucose-Lowering Agents and Gut Microbiota in Type 2 Diabetes Mellitus. Journal of Diabetes Research 2018, pages 1-7.
Crossref
Crossref
Faiza Malik, Syed Faizan Mehdi, Haroon Ali, Priya Patel, Anam Basharat, Amrat Kumar, Fnu Ashok, Joanna Stein, Wunnie Brima, Prashant Malhotra & Jesse Roth. (2018) Is metformin poised for a second career as an antimicrobial?. Diabetes/Metabolism Research and Reviews 34:4.
Crossref
Crossref
Ellie Sayers, Alex MacGregor & Simon R. Carding. (2018) Drug-microbiota interactions and treatment response: Relevance to rheumatoid arthritis. AIMS Microbiology 4:4, pages 642-654.
Crossref
Crossref
Zhang Wang, Somdutta Saha, Stephanie Van Horn, Elizabeth Thomas, Christopher Traini, Ganesh Sathe, Deepak K. Rajpal & James R. Brown. (2017)
Gut microbiome differences between metformin‐ and liraglutide‐treated T2
DM
subjects
. Endocrinology, Diabetes & Metabolism 1:1.
Crossref
Crossref
Sophie Montandon & François Jornayvaz. (2017) Effects of Antidiabetic Drugs on Gut Microbiota Composition. Genes 8:10, pages 250.
Crossref
Crossref
Fabrice Bonnet & André Scheen. (2017) Understanding and overcoming metformin gastrointestinal intolerance. Diabetes, Obesity and Metabolism 19:4, pages 473-481.
Crossref
Crossref
Yoshihito Fujita & Nobuya Inagaki. (2016) Metformin: clinical topics and new mechanisms of action. Diabetology International 8:1, pages 4-6.
Crossref
Crossref
M. Jecht. (2017) Effekte von Metformin auf die IntestinalmikrobiotaEffects of metformin on the gut microbiota. Der Diabetologe 13:2, pages 119-120.
Crossref
Crossref
Jacobo de la Cuesta-Zuluaga, Noel T. Mueller, Vanessa Corrales-Agudelo, Eliana P. Velásquez-Mejía, Jenny A. Carmona, José M. Abad & Juan S. Escobar. (2017)
Metformin Is Associated With Higher Relative Abundance of Mucin-Degrading
Akkermansia muciniphila
and Several Short-Chain Fatty Acid–Producing Microbiota in the Gut
. Diabetes Care 40:1, pages 54-62.
Crossref
Crossref
Yoshihito Fujita & Nobuya Inagaki. (2017) Metformin: New Preparations and Nonglycemic Benefits. Current Diabetes Reports 17:1.
Crossref
Crossref
Ralph A. DeFronzo, John B. Buse, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron & Mark Fineman. (2016) Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials. Diabetologia 59:8, pages 1645-1654.
Crossref
Crossref
John B. Buse, Ralph A. DeFronzo, Julio Rosenstock, Terri Kim, Colleen Burns, Sharon Skare, Alain Baron & Mark Fineman. (2016) The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies. Diabetes Care 39:2, pages 198-205.
Crossref
Crossref
Rosina PryorFilipe Cabreiro. (2015) Repurposing metformin: an old drug with new tricks in its binding pockets. Biochemical Journal 471:3, pages 307-322.
Crossref
Crossref
Mette Marie H. Christensen, Kurt Højlund, Ole Hother-Nielsen, Tore B. Stage, Per Damkier, Henning Beck-Nielsen & Kim Brøsen. (2015) Endogenous glucose production increases in response to metformin treatment in the glycogen-depleted state in humans: a randomised trial. Diabetologia 58:11, pages 2494-2502.
Crossref
Crossref
Nathalie M. Delzenne, Patrice D. Cani, Amandine Everard, Audrey M. Neyrinck & Laure B. Bindels. (2015) Gut microorganisms as promising targets for the management of type 2 diabetes. Diabetologia 58:10, pages 2206-2217.
Crossref
Crossref
G. C. Jones & C. A. R. Sainsbury. (2015) Comment on ‘A justification for less restrictive guidelines on the use of metformin in stable chronic renal failure’. Diabetic Medicine 32:2, pages 287-287.
Crossref
Crossref
Antonella Napolitano, Sam Miller, Andrew W. Nicholls, David Baker, Stephanie Van Horn, Elizabeth Thomas, Deepak Rajpal, Aaron Spivak, James R. Brown & Derek J. Nunez. (2014) Novel Gut-Based Pharmacology of Metformin in Patients with Type 2 Diabetes Mellitus. PLoS ONE 9:7, pages e100778.
Crossref
Crossref
Sven M Carlsen, Valdermar Grill & Ivar Følling. (1998) Evidence for dissociation of insulin- and weight-reducing effects of metformin in non-diabetic male patients with coronary heart disease. Diabetes Research and Clinical Practice 39:1, pages 47-54.
Crossref
Crossref
. 1996.
181
214
.
L. S. Hermann. 1996. Oral Antidiabetics. Oral Antidiabetics
373
407
.